Enzolytics ENZC Stock
Enzolytics Price Chart
Enzolytics ENZC Financial and Trading Overview
| Enzolytics stock price | 0.0010 USD |
| Previous Close | 0.001 USD |
| Open | 0.001 USD |
| Bid | 0.0008 USD x 88666600 |
| Ask | 0.001 USD x 247538400 |
| Day's Range | 0.001 - 0.001 USD |
| 52 Week Range | 0.0002 - 0.0013 USD |
| Volume | 22.94K USD |
| Avg. Volume | 11.83M USD |
| Market Cap | 4.83M USD |
| Beta (5Y Monthly) | 0.531 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ENZC Valuation Measures
| Enterprise Value | 228.49K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 103.69313 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.904 |
| Enterprise Value/EBITDA | -0.258 |
Trading Information
Enzolytics Stock Price History
| Beta (5Y Monthly) | 0.531 |
| 52-Week Change | 66.66% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.0013 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.000596 USD |
| 200-Day Moving Average | 0.000423 USD |
ENZC Share Statistics
| Avg. Volume (3 month) | 11.83M USD |
| Avg. Daily Volume (10-Days) | 13.5M USD |
| Shares Outstanding | 4.83B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.038% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:500 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2011 |
| Most Recent Quarter (mrq) | March 31, 2012 |
| Next Fiscal Year End | December 31, 2012 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1924.25% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -704.70% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 46.59K USD |
| Revenue Per Share (ttm) | 0.22 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 46.59K USD |
| EBITDA | -886773 USD |
| Net Income Avi to Common (ttm) | -1028513 USD |
| Diluted EPS (ttm) | -2.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.76K USD |
| Total Cash Per Share (mrq) | 0.005 USD |
| Total Debt (mrq) | 233.12K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.011 |
| Book Value Per Share (mrq) | -0.633 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -621041 USD |
| Levered Free Cash Flow (ttm) | 151.19K USD |
Profile of Enzolytics
| Country | United States |
| State | TX |
| City | Plano |
| Address | 2000 North Central Expressway |
| ZIP | 75074 |
| Phone | 972 292 9414 |
| Website | https://enzolytics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Enzolytics, Inc. a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics, Inc. is based in Plano, Texas.
Q&A For Enzolytics Stock
What is a current ENZC stock price?
Enzolytics ENZC stock price today per share is 0.0010 USD.
How to purchase Enzolytics stock?
You can buy ENZC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enzolytics?
The stock symbol or ticker of Enzolytics is ENZC.
Which industry does the Enzolytics company belong to?
The Enzolytics industry is Biotechnology.
How many shares does Enzolytics have in circulation?
The max supply of Enzolytics shares is 4.83B.
What is Enzolytics Price to Earnings Ratio (PE Ratio)?
Enzolytics PE Ratio is now.
What was Enzolytics earnings per share over the trailing 12 months (TTM)?
Enzolytics EPS is -2.5 USD over the trailing 12 months.
Which sector does the Enzolytics company belong to?
The Enzolytics sector is Healthcare.